Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response.
about
Cytokine production associated with smallpox vaccine responsesFilaggrin deficiency promotes the dissemination of cutaneously inoculated vaccinia virusDevelopment of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infectionMechanisms underlying helper T-cell plasticity: implications for immune-mediated disease.Praziquantel facilitates IFN-γ-producing CD8+ T cells (Tc1) and IL-17-producing CD8+ T cells (Tc17) responses to DNA vaccination in miceCationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections.α4-integrins control viral meningoencephalitis through differential recruitment of T helper cell subsets.The infectious aspects of atopic dermatitis.Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switchingPathological role of interleukin-17 in poly I:C-induced hepatitis.Tailored immune responses: novel effector helper T cell subsets in protective immunity.Immunization with modified vaccinia virus Ankara prevents eczema vaccinatum in a murine model of atopic dermatitis.Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.Susceptibility to vaccinia virus infection and spread in mice is determined by age at infection, allergen sensitization and mast cell statusIndividualized treatment strategies and predictors of virological response for chronic hepatitis C: a multicenter prospective study from China.Vaccinia Ig ameliorates eczema vaccinatum in a murine model of atopic dermatitis.Expanding roles for CD4⁺ T cells in immunity to viruses.Skin inflammation arising from cutaneous regulatory T cell deficiency leads to impaired viral immune responses.IL-10 suppresses IL-17-mediated dermal inflammation and reduces the systemic burden of Vaccinia virus in a mouse model of eczema vaccinatum.Bacterial and Viral Infections in Atopic Dermatitis: a Comprehensive Review.IL-1R Type 1-Deficient Mice Demonstrate an Impaired Host Immune Response against Cutaneous Vaccinia Virus Infection.Thymic stromal lymphopoietin and IL-33 promote skin inflammation and vaccinia virus replication in a mouse model of atopic dermatitis.Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype.Immune Response of A Novel ATR-AP205-001 Conjugate Anti-hypertensive Vaccine.Atopic dermatitis complicated by eczema herpeticum is associated with HLA B7 and reduced interferon-γ-producing CD8+ T cells.C3a receptor promotes viral containment in mice inoculated with vaccinia virus at sites of allergic skin inflammation.T helper type 1/T helper type 17-related cytokines in chronic hepatitis C patients before and after interferon and ribavirin therapy.
P2860
Q26823501-2419565B-E23E-42F1-A234-A0D10FBB333DQ27310377-A0EAA46D-85CC-423D-A3B2-AA229674A956Q27321985-E13E4115-284A-4128-97F4-065BFE2066E5Q27687830-162C397D-F3E8-4979-ACBC-37AA656A992CQ28477371-722C6969-4EB9-450F-A6C7-A607DBB64EC5Q30151971-2489685D-D9A8-47F1-814A-DF67CAFFBCACQ33642954-26ED35C9-F921-45A1-905B-211C5A1A1DB9Q34032522-9F6EECD4-F5F9-417F-82E6-FA004233B763Q34810232-F4788407-4AC0-4207-A1AB-6341EDEECC82Q34998903-7B44D43D-8ED9-44AD-9206-B3BB2703C9E9Q35105613-77143A66-9A92-404E-B73E-050CEDF9F64BQ35256115-7ADE5F04-85EC-4E5C-BD13-A0F32EB7AB4DQ35629472-AFD94C70-4F14-4994-9F03-64DC03F758DDQ35795457-DB7AF472-23F3-446F-9355-B369352B49E3Q36317352-B812A2F4-0809-4AE3-90B3-38C0F3B45668Q36642547-2E66512F-C302-4BAF-AD79-82D0AF4A7A37Q37150560-E44EF0D5-02CB-4F0C-986F-36B55C522681Q37414801-23FB8DC7-3D12-494D-9ED4-465D4B97F9B6Q37624292-BDF2D29B-E671-4740-9A0D-A43C0A4D5F62Q38885691-09F1EAA3-6FD9-448E-A7DE-A6536C60F8EFQ40216507-2C0BF4B5-8FAD-4EAE-831C-B9CEC68F8128Q40938928-6377ED98-5B87-4E71-99D8-CD6996DAB0B1Q41899031-6476521A-5691-4311-BAC1-0401C8C9A9ACQ41925097-A1E580FF-B9EA-4A14-AA3B-108BCFCA6FECQ44194769-2F404C7F-C713-4214-927B-9FE980E9DB34Q44531786-49BC7B50-E6A4-4338-ABC3-F83225405D11Q46494944-44937F41-09D2-498C-9417-B9E9668E84C1
P2860
Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vaccinia virus inoculation in ...... rous cutaneous IL-17 response.
@en
Vaccinia virus inoculation in ...... rous cutaneous IL-17 response.
@nl
type
label
Vaccinia virus inoculation in ...... rous cutaneous IL-17 response.
@en
Vaccinia virus inoculation in ...... rous cutaneous IL-17 response.
@nl
prefLabel
Vaccinia virus inoculation in ...... rous cutaneous IL-17 response.
@en
Vaccinia virus inoculation in ...... rous cutaneous IL-17 response.
@nl
P2093
P2860
P356
P1476
Vaccinia virus inoculation in ...... rous cutaneous IL-17 response.
@en
P2093
Abdallah Elkhal
Donald Y M Leung
George F Murphy
Hans C Oettgen
Jordan E Scott
Lalit Kumar
Michael D Howell
Michiko K Oyoshi
Raif S Geha
P2860
P304
14954-14959
P356
10.1073/PNAS.0904021106
P407
P577
2009-08-17T00:00:00Z